Amin Rostami-Hodjegan
Chief Tech/Sci/R&D Officer at CERTARA, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Feehery | M | 54 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 5 years |
James Cashman | M | 70 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 6 years |
Richard Traynor | M | 53 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 6 years |
Stephen McLean | M | 66 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 11 years |
Matthew Walsh | M | 57 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 7 years |
Nancy Rothwell | M | 68 |
The University of Manchester
| - |
Nancy Killefer | F | 69 | 3 years | |
David Spaight | M | 65 | 2 years | |
Rosemary Crane | F | 64 | 2 years | |
Leif Pedersen | M | 60 | 4 years | |
Robert Eric Hough | M | 79 |
The University of Manchester
| - |
Eran Broshy | M | 65 | 2 years | |
Cynthia Collins | F | 65 | 3 years | |
Ellen Leinfuss | F | - |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | - |
Paul Brenchley | M | - |
The University of Manchester
| - |
John Gallagher | M | 51 | 1 years | |
Ethan Waxman | M | 35 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 4 years |
Dame Angela Strank | M | 71 |
The University of Manchester
| - |
Kevin O'Brien | M | - |
The University of Manchester
| - |
Diane Coyle | M | - |
The University of Manchester
| 10 years |
Norman Brian M. Askew | M | 82 |
The University of Manchester
| - |
Philip Bruce Morgan | M | 55 |
The University of Manchester
| - |
Jaap Mandema | M | - | - | |
Ian Kimber | M | 74 |
The University of Manchester
| - |
Jacky Smith | F | - |
The University of Manchester
| - |
Bridget Lea | F | - |
The University of Manchester
| 6 years |
Nicolette Sherman | F | - | 3 years | |
Robert Aspbury | M | 53 | 4 years | |
Josh Xie | M | - | 3 years | |
Xiao Chun Guo | M | 42 |
The University of Manchester
| - |
John Stageman | M | - |
The University of Manchester
| - |
Aimin Song | M | - |
The University of Manchester
| - |
Geoffrey James Martin Parker | M | - |
The University of Manchester
| - |
Jon Roland Sayers | M | - |
The University of Sheffield
| 29 years |
Mark Hovde | M | 67 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | - |
Edward M. Astle | M | 70 |
The University of Manchester
| - |
Caroline Johnstone | F | 64 |
The University of Manchester
| - |
Sheila Yeomans | F | - |
The University of Manchester
| 20 years |
Neville B. Richardson | M | 66 |
The University of Manchester
| - |
Ian Horrocks | M | - |
The University of Manchester
| - |
Ted Roberts | M | - |
The University of Manchester
| - |
Roger Bruce Pettman | M | 68 |
The University of Manchester
| - |
Stephen Shuttleworth | M | - |
The University of Manchester
| 10 years |
Charles McCollum | M | - |
The University of Manchester
| - |
Stephen Toon | M | 68 |
The University of Manchester
| - |
Ivan T. Robertson | M | - |
The University of Manchester
| - |
Karl Wills | M | - |
The University of Manchester
| - |
Paul O'Brien | M | - |
The University of Manchester
| - |
Sandra Downes | M | - |
The University of Manchester
| - |
Mason Slaine | M | 71 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | - |
Anil Kumar Ruia | M | 68 |
The University of Manchester
| - |
Cristiano Antonelli | M | 73 |
The University of Manchester
| - |
Michael Schemick | M | 50 |
Certara USA, Inc.
Certara USA, Inc. Miscellaneous Commercial ServicesCommercial Services Certara USA, Inc. provides drug development consultancy solutions. It offers benefits of modeling and simulation, label optimization, pediatric drug development, orphan drug development, clinical trial outcomes databases, and therapeutic areas. The company was founded in 2008 and is headquartered in Princeton, NJ. | 10 years |
Patrick Smith | M | - | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jessica Hope | F | - |
The University of Manchester
| 4 years |
Ahmed Al-Shamsi | M | - |
The University of Manchester
| 6 years |
Yara Essam Qasim Baddar | M | 39 |
The University of Manchester
| 10 years |
Jia Ming He | M | 38 |
The University of Manchester
| 5 years |
Wei Dong Chen | M | 36 |
The University of Manchester
| 4 years |
Man Tim Cheung | M | 40 |
The University of Manchester
| 5 years |
David Harrison | M | 46 |
The University of Sheffield
| 4 years |
Pavlos Karydas | M | 49 |
The University of Manchester
| 5 years |
Tan Shyue Wern | M | - |
The University of Manchester
| 1 years |
Lim Chee Peng | M | - |
The University of Sheffield
| 5 years |
Caroline de la Soujeole | F | - |
The University of Manchester
| 5 years |
Josh Bean | M | - |
The University of Manchester
| 3 years |
Faraaz Karim Chowdhury | M | - |
The University of Manchester
| 1 years |
Shin Lid Lim | M | 49 |
The University of Sheffield
| 3 years |
Daniel Ireland | M | - |
The University of Manchester
| 3 years |
Ed Brentnall | M | - |
The University of Sheffield
| 3 years |
Orna Carni | F | - |
The University of Manchester
| 1 years |
Reena Sharma | F | - |
The University of Manchester
| 3 years |
Xingyuan Lyu | M | 34 |
The University of Manchester
| 2 years |
Xing Yuan Lv | M | 34 |
The University of Manchester
| 1 years |
Courtney Walker | F | - |
The University of Manchester
| 4 years |
Eric Bright | M | - |
The University of Manchester
| 3 years |
Natalie Evans | F | - |
The University of Manchester
| 4 years |
Peck Woon Law | F | 45 |
The University of Sheffield
| 4 years |
Su Hui Yeoh | F | 51 |
The University of Sheffield
| 3 years |
Cheng Sye Phua | M | 55 |
The University of Sheffield
| 4 years |
Ed Prior | M | - |
The University of Manchester
| 3 years |
Yat Ming Cheung | M | 62 |
The University of Sheffield
| 4 years |
John Garner | M | - |
The University of Sheffield
| 4 years |
Chang Ching Lim | F | 50 |
The University of Sheffield
| 4 years |
Dimitris A. Koutsoupias | M | 56 |
The University of Sheffield
| 2 years |
Choon Hou Ho | M | 52 |
The University of Sheffield
| 4 years |
Rohit Ambekar Madhukar | M | - |
The University of Sheffield
| 4 years |
Azhar bin Ahmad | M | 52 |
The University of Sheffield
| 4 years |
Yan Wai Lau | M | 45 |
The University of Sheffield
| 5 years |
An Tai Lin | M | 52 |
The University of Sheffield
| 2 years |
Jonathan Andrew Clapham | M | - |
The University of Manchester
| 3 years |
Joanna Claire Allen | F | 48 |
The University of Sheffield
| 3 years |
Mohammed Zainul F. bin Othman | M | 59 |
The University of Sheffield
| 3 years |
Tim Higgenbottam | M | - |
The University of Sheffield
| 6 years |
Chuan-Chih Pan | M | 55 |
The University of Sheffield
| 4 years |
Eric Bentov | M | - |
The University of Sheffield
| 3 years |
Rob King | M | - |
The University of Manchester
| 3 years |
Hock Leong Ee | M | 51 |
The University of Sheffield
| 4 years |
Benjamin William Howard | M | 49 |
The University of Sheffield
| 4 years |
On Tai Lam | M | 52 |
The University of Sheffield
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United Kingdom | 78 | 78.00% |
United States | 22 | 22.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Amin Rostami-Hodjegan
- Personal Network